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Abstract
Background: Voltage-sensitive dye (VSD) imaging and intrinsic optical signals (IOS) are widely used methods for
monitoring spatiotemporal neural activity in extensive networks. In spite of that, identification of their major cellular
and molecular components has not been concluded so far.
Results: We addressed these issues by imaging spatiotemporal spreading of IOS and VSD transients initiated by
Schaffer collateral stimulation in rat hippocampal slices with temporal resolution comparable to standard field
potential recordings using a 464-element photodiode array. By exploring the potential neuronal and astroglial
molecular players in VSD and IOS generation, we identified multiple astrocytic mechanisms that significantly
contribute to the VSD signal, in addition to the expected neuronal targets. Glutamate clearance through the
astroglial glutamate transporter EAAT2 has been shown to be a significant player in VSD generation within a very
short (<5 ms) time-scale, indicating that astrocytes do contribute to the development of spatiotemporal VSD
transients previously thought to be essentially neuronal. In addition, non-specific anion channels, astroglial K+
clearance through Kir4.1 channel and astroglial Na
+/K+ ATPase also contribute to IOS and VSD transients.
Conclusion: VSD imaging cannot be considered as a spatially extended field potential measurement with
predominantly neuronal origin, instead it also reflects a fast communication between neurons and astrocytes.
Keywords: Voltage-sensitive dye, Intrinsic optical signal, Astrocyte, Excitatory amino-acid transporter type 2,
Hippocampus, Field potential, Photodiode-array
Background
Understanding brain (dys)functions necessitates valid rep-
resentations of spatiotemporal dynamics of neural activity.
For this purpose, two major approaches are used, the
electrophysiology based multielectrode arrays (MEA) [1]
and the optical signal based methods [2]. The MEA-based
activity mapping takes advantage of the well-characterized
electrophysiological signal with exceptionally high tem-
poral resolution. However, the method also suffers from
several important drawbacks, including the limited spatial
resolution and severe invasiveness. Spatiotemporal optical
imaging approaches offer a solution to overcome these
limitations. However, despite the considerable efforts to
uncover the cellular and molecular processes underlying
the genesis and spreading of optical signals [3–6],
important details of these processes and especially the role
of glial cells and neuro-glia interactions still remained ob-
scure. We addressed the identification of neuronal and glial
target proteins underlying optical imaging of neural activity
by comparing two widely used [7–12] optical methods, the
intrinsic optical signal (IOS) and the voltage-sensitive dye
(VSD) imaging.
The label-free IOS [13], enabling non-invasive map-
ping of patients’ neuronal activity under intra-operative
conditions [14, 15], generally considered to measure
light scattering changes [8] due to activity-dependent
cell swelling [5, 8, 16]. Recently, however, several other
physiological processes, including astroglial glutamate
uptake and neuro-glia coupling has also been identified
as significant contributors to the generation of intrinsic
optical signal [17–22].
VSDs bind to the extracellular part of the cell mem-
brane and transforms electrical activity to optical signal
[4]. In contrast to IOS, the VSD transients operate on time
scale similar to field potential (FP) recording, however,
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significant differences in the signal length of locally re-
corded FP and VSD transients have also been observed
[23–25]. VSD imaging is typically considered as the op-
tical counterpart of FP measurements and is used for
expanding the one-dimensional FP when the multi-
electrode arrays cannot be applied due to their invasive-
ness or low spatial resolution [26–28].
To determine how neuronal and astroglial activity is
coupled to spatiotemporal optical signals we measured
the regional distribution and spreading pattern of IOS
and VSD transients following brief Schaffer collateral
stimulation in rat hippocampal slices and compared the
two spatiotemporal signals to each other and also to the
FP measured locally in the CA1. By pharmacological
inhibition of several possible neuronal and astroglial
molecular targets (Glu receptors, major astroglial Glu
transporter, neuronal K+/Cl− cotransporter KCC2, Na+/
K+/Cl− cotransporter NKCC1, non-specific Cl− channels,
Kir4.1 potassium channel and Na
+/K+ ATPase) we assessed
their role in IOS and VSD signal generation.
Results
Spatiotemporal pattern of stimulation evoked VSD and
IOS transients in the rat hippocampal slice
To assess the molecular determinants of IOS and VSD
signals we stimulated the Schaffer collateral in 400 μm
thick rat hippocampal slices and measured the resulting
changes in the label-free intrinsic optical signal (IOS)
and in the absorbance of the NK3630 voltage-sensitive
dye (VSD) in the whole hippocampus with a high-
frequency sampling rate (~1.6 kHz) imaging device, a
464-element photodiode array (PDA) detector. The high
sampling frequency of the PDA enables the temporal
alignment of the optical signals with the simultaneously
measured field potential (FP). Fig. 1b shows the relation
between the time scales of the optical signals and the
FP. IOS is approximately 12 times longer than the FP,
while the length of the VSD transient is similar to the
FP time scale.
To determine whether optical signals correlate to the
electrophysiological signal, the amplitude of the popula-
tion spike (PS) measured in the CA1 str. pyramidale was
compared to the summa amplitude of each optical signal
in the whole CA1. The amplitude of the population
spike measures the synchronous firing of the neighbor-
ing neurons [29]. In addition, to further strengthen the
parity of the electrophysiological and optical signals, PS
amplitude was also compared to the optical signal ampli-
tudes measured on the single diode at the FP recording
site. Furthermore, summa amplitudes of the IOS and
VSD signals in the CA1, CA3 and dentate gyrus (DG)
regions of the hippocampus were also compared to each
other to evaluate regional differences in the generation
of the two optical signals.
Both IOS and VSD amplitudes measured in the close
vicinity of the recording electrode in the CA1 pyramidal
layer were found to be linearly correlating with the PS
amplitude (R2 = 0.98), suggesting that IOS and VSD
linearly follow neuronal activity. Spatial distribution
patterns of VSD and IOS showed highest amplitudes in
the CA1 str. pyramidale and proximal str. radiatum
(Fig. 1a), corresponding to the innervated area of the
stimulated Schaffer collaterals. Both signals were also
detected in the CA3 pyramidal layer most probably due
to antidromic stimulation [30] and the activation of the
CA3 to CA3 associational projections [31]. In 72/100
slices the activated area also included the DG showing
the activation of mossy fibers.
The amplitude distributions in the CA1 were similar
for the VSD and IOS signals, but they were found to be
different in the CA3 region. In the CA3 region IOS
showed the highest amplitude transients in the pyram-
idal layer and in the proximal radiatum, while the high-
est VSD amplitude was observed in the distal radiatum.
This phenomenon can arise from the different way of
stimulation (orthodromic vs. antidromic) or the different
mechanisms underlying the two optical signals.
The dynamics of both optical signals were also signifi-
cantly different in the CA3 and CA1. In the antidromi-
cally stimulated CA3, IOS transients in the str. radiatum
were found to be smaller than in the pyramidal layer,
while in the orthodromically activated CA1, IOS traces
in the str. radiatum overshot those recorded in the str.
pyramidale [5]. Contrary, the VSD transients in the CA3
str. radiatum were higher than in the pyramidal layer,
while in the CA1 transients in the str. radiatum were
smaller than in the pyramidal layer (Fig. 1a). The sub-
regional activation pattern of the VSD was also different
in the CA1 and CA3 as traces in the str. oriens of the
CA1 rose significantly later than the traces in the str.
radiatum, opposite to the pattern obtained in the CA3
(Fig. 1c insert). Despite of the differences between the
time scales of the two optical signals, both signals can be
applied to discriminate between orthodromic (CA1) and
antidromic (CA3) activation patterns.
Shapes of the VSD signals in the str. pyramidale and
str. oriens of the CA1 were different from those of the
CA3 but in the str. radiatum they were very similar in
the CA1 and CA3 (Fig. 1c).
The high-frequency sampling rate of the PDA device
allowed us to temporally dissect IOS and VSD gener-
ation processes (Fig. 1d). As it was previously shown [5],
IOS appears first in the CA1 str. pyramidale at Schaffer
collateral end points than in the str. radiatum and other
parts of the str. pyramidale of the CA1 and CA3. Subse-
quently, it spreads along the pyramidal layer in the str.
radiatum towards the stimulating electrode and the
subiculum [5].
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Fig. 1 Spatial characteristics of VSD and IOS transients. a: 2D representation of the VSD (left) and IOS (right) amplitude distribution in the
hippocampal slice. Optical signals were recorded from the same NK3630 stained slice. b: Time course of the field potential responses and
the VSD (left) and the IOS (right) transients on the diode at the field potential recording site evoked by a single stimulus (VSD) or a stimulus train
(10 stimuli, 20 Hz, IOS). Signals were recorded from the two different slices. IOS was recorded from an unstained slice while VSD was recorded
from a stained slice. c: (Left) Spatial overview of the VSD transient pattern on the 464-element photodiode array. Transparent lines indicate the
pyramidal cell layers (CA1 and CA3) and the granular cell layer of the DG. The position of the stimulating electrode is marked by an arrow. (Right)
Comparison of the profile of VSD traces along the somato-dendritic axis of CA1 (black lines) and CA3 (red lines) regions. Inserts show the first 40
ms of the traces following stimulation onset. d: 2D representation of the VSD and IOS spreading patterns. Spreading is represented by the time
required for the optical signal to reach 50 % of its amplitude following the stimulus onset. Transparent lines indicate the pyramidal cell layers
(CA1 and CA3) and the granular cell layer of the DG. The positions of the stimulating and recording electrodes are marked by gray and green
arrows, respectively
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There are several possible explanation for the observed
temporal appearance of IOS. Schaffer collaterals sur-
round the pyramidal layer from both sides (str. radiatum
and str. oriens) [32], therefore the somatic layer might
have a higher concentration of neurotransmitters to in-
duce IOS. Another explanation is that IOS reaches de-
tection limit earlier in the somatic region of pyramidal
cells than in the dendritic region. Since the extracellular
volume is the smallest in the pyramidal layer in the CA1
[33], small changes in cell volume in this layer might
lead to drastic changes in light scattering. Alternatively,
neuronal swelling might arise faster than glial swelling.
It is still not clear how neurons swell under physiological
conditions [34]. There is evidence that the swelling of
the axons is a fast process, it occurs on a similar time
scale to action potential generation (1–10 ms) [35–37]
so swelling of the axon initial segment may be observed
earlier. This is in agreement with the relatively early IOS
response in the str. oriens. Since cortical neurons lack
functional water channels, Andrew and coworkers
supposed that neurons swell by opening non-aquaporin
channels to water [38], like potassium channels that are
permeable to water [39].
The VSD signal had completely different temporal ap-
pearance and spreading pattern. Following the stimulation,
VSD signal appeared first near the stimulating electrode
than spread along the pyramidal layer towards the subicu-
lum or the DG, parallel in the CA1 and the CA3 (Fig. 1d).
It is to note that the two signals are on a different time
scale, VSD traverses the hippocampal slice in ~12 ms
while IOS needs more than a second to fully propagate.
Therefore the spreading pattern of IOS does not follow
the sequence of neural depolarization indicated by the
VSD signal. The estimated spreading velocity of the VSD
signal is 300 ± 80 μm/ms, which is three orders of magni-
tude faster than that of the IOS (0.23 ± 0.05 μm/ms) and is
in the range of the spreading velocity of the field potential
signal (240 ± 12 μm/ms), showing that VSD imaging can
reliably follow neuronal activity.
Neuronal activation is required for IOS and VSD
To examine whether VSD signal is evoked by synaptic
activation following the Schaffer collateral stimulation
we applied the voltage-gated sodium channel inhibitor
tetrodotoxin (TTX, 5 μM). TTX completely eliminated
the PS (0 ± 1 % of control, N = 5) and the VSD signals (1 ±
0.4 % of control, N = 5), demonstrating that the passive
voltage propagation in the tissue is insufficient to evoke
VSD. Therefore VSD signal is strictly initiated by neuronal
activation.
Enhancement of neuronal activity by applying the
GABAA receptor antagonist picrotoxin (100 μM) in-
creased both PS (357 ± 26 % and 312 ± 20 % of control,
N = 5 and N = 8 for IOS and VSD measurements,
respectively) and optical signal amplitudes in all the ex-
amined regions to 135–200 %. The picrotoxin-induced
increase of the optical signal amplitudes in the CA1 was
less pronounced than that of the PS amplitude (PSIOS:
468 ± 46 %, PSVSD: 592 ± 71 %, IOS in CA1: 135 ± 17 %,
VSD in CA1: 182 ± 12 % of control). Increase of IOS
amplitude was also significantly smaller than that of
VSD in the CA3 region (IOS in CA3: 137 ± 11 %, VSD
in CA3: 168 ± 10 % of control). Interestingly, the changes
in the VSD signal showed no regional differences, while
IOS increase was significantly more pronounced in the
DG than in the CA1 and the CA3 regions. Both optical
signals were also increased at the FP recording site (IOS:
192 ± 49 %, VSD: 158 ± 10 % of control).
Blockade of astrocytic Glu uptake distinguishes among
FP, IOS and VSD measures of neural activity
To assess the contribution of glutamatergic processes to
the VSD signal and IOS generation, we measured these
signals in the presence of ionotropic Glu receptor antago-
nists and Glu transporter blocker. Simultaneous inhibition
of 2-amino-3-(5-methyl-3-oxo-1,2-oxazol-4-yl)propanoic
acid (AMPA)/kainate receptor by CNQX (6-cyano-7-
nitroquinoxaline-2,3-dione, 20 μM) and NMDA receptor
by APV (DL-2-amino-5-phosphonopentanoic acid, 100
μM) completely eliminated the PS amplitude (PSIOS:
0 ± 0 %, PSVSD: 0 ± 0 % of control) and significantly de-
creased the amplitude of IOS (16 ± 6 %, 23 ± 10 % 23 ± 6
% and 0 ± 0 % of control in the CA1, CA3 DG and at the
FP recording site, respectively) and VSD signal (7 ± 2 %,
32 ± 7 %, 32 ± 12 % and 11 ± 11 % of control in the CA1,
CA3 DG and at the FP recording site, respectively,
Fig. 2a). There were no significant regional differences
in either VSD or IOS, but the ratio of IOS and VSD sig-
nals was significantly different in all regions compared
to control (Table 1), suggesting regional differences be-
tween the contribution of the ionotropic glutamatergic
receptors to IOS and VSD signals. In summary, the
majority of all the three signals require preceding post-
synaptic glutamatergic activity.
DHK (dihyrokainic acid, 300 μM), a selective blocker
of the glial Glu transporter EAAT2 increased the PS
amplitude (PSIOS: 141 ± 19 %, PSVSD: 143 ± 8 % of control,
Fig. 2b) most probably due to the increased extracellular
Glu concentration [40, 41]. Importantly, however, VSD
and IOS amplitudes decreased in all regions of the hippo-
campus (VSD: 69 ± 2 %, 19 ± 1 %, 10 ± 2 % of control in
the CA1, CA3 and in the DG, respectively; IOS: 54 ± 8 %,
38 ± 4 %, 31 ± 6 % of control in the CA1, CA3 and in the
DG, respectively). Therefore, both IOS and the VSD sig-
nals were decoupled from neuronal firing, which is also
indicated by the significant difference of the IOS/PS and
VSD/PS ratios from the control (Table 1). These suggest
that both VSD and IOS have a component that is directly
Pál et al. Molecular Brain  (2015) 8:35 Page 4 of 20
related to the glial Glu transporter EAAT2, indicating
that a large component of the optical signals has glial
origin. This component may be attributed to the EAAT2
mediated glial cell swelling (in IOS signal), or glial
depolarization via the EAAT2 (in VSD signal).
The fact that not only IOS, but also VSD decreased in
the presence of DHK in parallel with the increasing PS
amplitude could be the result that we measured the field
potential locally in the CA1 str. pyramidale and com-
pared it to summa VSD amplitude in the whole CA1. To
Fig. 2 Contribution of glutamatergic activity to VSD and IOS transients. a: (Left) Representative VSD amplitude maps under control condition and
100 μM APV + 20 μM CNQX application. (Right) Effect of 100 μM APV + 20 μM CNQX application on the population spike (PS) measured in the
CA1 and on the average VSD and IOS amplitudes in the CA1, CA3 and DG regions. b: (Left) Representative IOS and VSD amplitude maps under
control condition and 300 μM DHK application. (Middle) Time course of the field potential responses and VSD transients on the diode at the field
potential recording site under control conditions and during 300 μM DHK application. (Right) Effect of 300 μM DHK on the PS measured in the
CA1 and on the average VSD and IOS amplitudes in the CA1, CA3 and DG regions. c: (Left) Distribution of inhibitory effect of 100 μM APV + 20
μM CNQX application on the VSD amplitude of each diodes in % of control. The valley between the two peaks on the histogram is marked by an
arrow. (Middle) Representative VSD inhibition map during 100 μM APV + 20 μM CNQX + 300 μM DHK application in % of control. Area identified as
monosynaptically activated is contoured by white line. (Right) Effect of 100 μM APV+ 20 μM CNQX+ 300 μM DHK on the PS measured in the CA1 and
on the average VSD amplitude in the monosynaptically activated area. On the optical signal amplitude maps transparent lines indicate the pyramidal
cell layers (CA1 and CA3) and the granular cell layer of the DG. The positions of the stimulating and recording electrodes are marked by gray
and green arrows, respectively. Asterisks indicate significant changes compared to control (P < 0.05, Mann–Whitney U test)
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address this issue we calculated the effect of DHK on
the single diode where the FP recording electrode was
located. We found that even at the location of the re-
cording electrode the VSD signal decreased to 84 ± 3 %
of control in the presence of DHK. This further substan-
tiates that astroglial Glu uptake via EAAT2 is a major
molecular determinant of the VSD signal even in the
short (<5 ms) time-scale, which is in contrast to previous
studies [6] that concluded astrocytic glutamate transport
contribution only to the slow depolarizing response (>10
ms). We have also seen EAAT2 contribution to the slow
depolarizing response as the integral of the VSD signal
was significantly decreased to 51 ± 4 % of control in the
presence of DHK, in agreement with the results of
Kojima and coworkers [6]. It is to note that IOS was also
decreased at the FP recording site (57 ± 11 % of control).
To confirm the strikingly fast contribution of the glial
Glu transporter to VSD signals and to quantitatively de-
termine its contribution, we measured the VSD inhibi-
tory effect of DHK at the monosynaptically activated
regions. Differentiating between mono- and polysynapti-
cally activating areas is necessary because the increased
extracellular Glu level leads to enhanced postsynaptic
and polysynaptic activation potentially masking the
EAAT2-mediated VSD signal components. In the mono-
synaptically activated regions, however, the contribution
of iGluR- and EAAT2-mediated components can be dir-
ectly measured and quantified. To quantitatively determine
the contribution of EAAT2 transporter to the monosynap-
tic component of the VSD signal we sequentially applied
iGluR inhibitors (CNQX and APV) followed by additional
DHK (CNQX, APV and DHK). The mono- and polysynap-
tically activated regions were distinguished by the differen-
tial effect of iGluR inhibitors on the VSD signal (iGluR
inhibition is stronger at polysynaptically activated areas
due to the higher number of synapses involved in their
activation). Indeed, the histograms of the iGluR inhibitor
effects showed bimodal distribution (Fig. 2c). The area
where APV and CNQX decreased the VSD signal by less
than 78 % (the valley between the two peaks on the histo-
gram) was considered to be monosynaptically activated
(Fig. 2c). Afterwards, the effect of additional DHK was
calculated in this region. We found that when DHK was
added to the iGluR inhibitors the amplitude of the VSD
signal was further decreased by 11 ± 1 % of control in
this region (one way ANOVA, p = 0.0013, Fig. 2c) com-
pared to iGluR inhibitors alone (32 ± 3 % of control,
N = 6). Therefore a large part of the VSD signal (>10 %)
is directly mediated by the glial Glu transporter EAAT2.
VSD in the CA1 and the CA3 regions decreased sig-
nificantly more than IOS in the same regions. Interesting
to note that contrary to the uneven IOS distribution,
VSD amplitudes were significantly different in all regions
(Fig. 2b). The most striking difference (50 ± 2 % of con-
trol) was found between the CA1 and the CA3 regions.
In addition to the orto- vs. antidromic activation, these
substantial differences can be attributed to regional dif-
ferences in EAAT2 expression. To address this issue,
immunohistochemistry measurements were performed.
We found that EAAT2 protein level is higher in the CA3
region than in the CA1 region (Fig. 3) which can account
for the regional differences of the EAAT2 mediated VSD
signal component. These results are in agreement with
previous studies showing that EAAT2 is more abundant
in the CA3 and the dentate gyrus, compared to CA1 [42].
The effect of DHK was reversible as up to 70 % of
control of the field response and optical signals were
regenerated after 15 min washout. Therefore we can
exclude the excitotoxic neuronal death.
In summary, in contrast to the Glu receptors, inhibition
of the glial Glu transporter, EAAT2 strikingly discrimi-
nated between the field potential and both optical signals.
Table 1 Differential effects of molecular target inhibitions on FP, VSD and IOS signals. Ratio of drug effects on optical signals and
population spikes. Ratios were calculated by dividing the change in optical signal amplitude due to drug application (expressed in
% of control) by the change in population spike or VSD amplitude (also expressed in % of control). Asterisks indicate significant
changes compared to control (P < 0.05 Mann–Whitney U test). NA means not applicable (PS amplitude is 0 mV)
Molecular target (inhibitor) VSD/PS ratio IOS/PS ratio IOS/VSD ratio IOS/VSD ratio IOS/VSD ratio
CA1 CA1 CA1 CA3 DG
Control 0.90 ± 0.05 1.05 ± 0.02 1.09 ± 0.05 1.06 ± 0.06 1.03 ± 0.05
GluR receptors (CNQX + APV) NA NA 1.78 ± 0.30* 0.55 ± 0.22* 0.36 ± 0.13*
EAAT2 (DHK) 0.53 ± 0.04* 0.53 ± 0.08* 0.77 ± 0.16 1.98 ± 0.33* 5.68 ± 2.02*
KCC2 and NKCC1 (furosemide) 0.81 ± 0.10 0.43 ± 0.07* 0.45 ± 0.06* 0.46 ± 0.04* 0.32 ± 0.08*
NKCC1 (bumetadine) 0.93 ± 0.06 1.17 ± 0.07 0.94 ± 0.04 1.05 ± 0.05 1.09 ± 0.13
KCC2 (VU0463271) 0.53 ± 0.08* 0.53 ± 0.16* 1.00 ± 0.10 1.00 ± 0.10 0.91 ± 0.10
Anion channels (DIDS) 0.62 ± 0.05* 0.41 ± 0.07* 0.67 ± 0.08* 0.59 ± 0.08* 0.61 ± 0.11*
Kir4.1 (BaCl2) 0.65 ± 0.06* 0.8 ± 0.09* 1.29 ± 0.12 1.5 ± 0.12* 3.03 ± 0.75*
Na+/K+ ATPase (ouabain) 0.71 ± 0.09 0.63 ± 0.15 1.13 ± 0.12 1.10 ± 0.10 1.39 ± 0.10*
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The Na+/K+/Cl− cotransporter NKCC1 does not
differentiate VSD and IOS signals
NKCC1 is mainly expressed on astrocytes and transports
Na+, K+ and Cl− ions into the cell [43]. It is proposed to
have a crutial role in the astrocytic K+ clearance [44].
The K+/Cl− cotransporter KCC2 transports Cl− and K+
ions out of the cells and is crucial for the maintenance
of neuronal intracellular [Cl−] [45]. The precise balance
between the activities of the two transporters is needed
to maintain inhibitory GABAergic signaling in the adult
central nervous system [46]. We have previously showed
[5] that the simultaneous inhibition of KCC2 and
NKCC1 by furosemide (5 mM) had distinct effects on
the PS and IOS. To determine whether IOS also differs
from the spatial VSD signal, we examined the effect of
furosemide on the VSD signal.
We observed that furosemide (5 mM) increased the PS
amplitude (PSIOS: 267 ± 37 %, PSVSD: 193 ± 16 % of con-
trol) in the VSD and IOS experiments, likely due to the
impaired GABAA receptor mediated inhibitory function
[47] or the reduced K+ driving force [48]. Parallel to the
PS changes, the VSD signal amplitude also increased in all
regions (140 ± 6 %, 140 ± 5 %, 129 ± 10 % and 159 ± 15 %
of control in the CA1, CA3 DG and at the FP recording
site, respectively; Fig. 4a). In contrast, IOS amplitude
decreased in all regions (63 ± 6 %, 64 ± 5 %, 41 ± 12 % and
57 ± 21 % of control in the CA1, CA3, DG and at the FP
recording site, respectively, Fig. 4a). Therefore, IOS, but
Fig. 3 EAAT2 protein level is higher in the CA3 than in the CA1 region. a: The topographical distribution of EAAT2 is demonstrated in a coronal
section. EAAT2 immunoreactivity is the most abundant in the CA3 region of the hippocampus and the dentate gyrus. However, EAAT2 immunoreactivity
is also present in the CA1 region. b: A high magnification picture of the framed area in the CA3 region of the section shown in A is presented. Glial cell
bodies are labeled in the pyramidal cell layer and adjacent part of str. oriens. Additional puncta-like labeling is seen throughout the str. radiatum
and str. oriens representing astrocytic processes in these layers. c: A high magnification image of the framed area in the CA1 in A. EAAT2
immunolabeling is present in astrocytes distributed in str. oriens while faintly labeled cells are also present in str. radiatum. Scale bar = 500 μm
for A and 100 μm for B and C
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Fig. 4 The Na+/K+/Cl− cotransporter NKCC1 does not differentiate VSD and IOS signals. a: (Left) Representative VSD amplitude maps under control
condition and 5 mM furosemide application. Transparent lines indicate the pyramidal cell layers (CA1 and CA3) and the granular cell layer of the
DG. The positions of the stimulating and recording electrodes are marked by gray and green arrows, respectively. (Middle) Time course of the
field potential responses and VSD transients on the diode at the field potential recording site under control condition and 5 mM furosemide
application. (Right) Effect of 5 mM furosemide on the population spike (PS) measured in the CA1 and on the average VSD and IOS amplitudes in
the CA1, CA3 and DG regions. b: Effect of 10 μM bumetanide on the PS measured in the CA1 and on the average VSD and IOS amplitudes in the
CA1, CA3 and DG regions. c: Effect of 10 μM VU0463271 on the PS measured in the CA1 and on the average VSD and IOS amplitudes in the CA1,
CA3 and DG regions. Asterisks indicate significant changes compared to control (P < 0.05, Mann–Whitney U test)
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not VSD decoupled from PS, indicated by the ratios of
IOS and VSD signals that were significantly different in all
regions compared to control (Table 1). Neither optical sig-
nal showed significant regional differences in drug effect,
in line with the uniform expression pattern of the trans-
porters [49]. The differential changes in IOS and VSD
amplitudes confirm that a furosemide-sensitive molecular
mechanism plays a crucial role in IOS generation.
After 15 min of washout major fractions of the PS
and IOS was recovered, therefore neuronal death can
be excluded.
Previous studies suggested that the effect of furosem-
ide on IOS is mediated by the blockade of NKCC1
resulting in reduced glial swelling [8, 50] or reduced glial
K+ clearance via the transporter [51]. However, bumeta-
nide (10 μM), a specific antagonist of NKCC1 did not
affect IOS amplitude in any region (104 ± 5 %, 102 ± 5 %,
and 94 ± 3 % of control in the CA1, CA3 and DG, re-
spectively; Fig. 4b), although the PS amplitude decreased
to 80 ± 4 % of control. The decreased PS amplitude may
be explained by the reported hyperpolarizing shift of the
Cl− reversal potential by inhibition of NKCC1 that leads
to increased efficacy of GABAergic inhibition [52]. IOS
amplitude was also unaffected on the diode at the loca-
tion of the recording electrode (94 ± 3 % of control).
In the presence of bumetanide the VSD signal in-
creased in the CA1 to 110 ± 3 % of control, did not sig-
nificantly change in the CA3 and at the FP recording
site (97 ± 4 % of control and 106 ± 4 % of control,
respectively) and decreased in the DG to 77 ± 7 % of
control (Fig. 4b). Accordingly, the PS amplitude in the
CA1 increased to 119 ± 4 % of control. The increased
population spike amplitude can again be explained by
impaired GABAA receptor mediated inhibitory function
[47] or the reduced K+ driving force [48]. Opposite to
the IOS, VSD signal was not decoupled from neuronal
activity by bumetanide, since PS amplitude in the CA1
and the VSD signal in the whole CA1 changed in a similar
manner. Neither the optical signal/PS ratios nor the IOS/
VSD ratio were significantly different from the control
(Table 1). The differences between the changes of the PS
amplitude in the case of IOS and VSD signal experiments
could be accounted for the different stimulation protocol.
Since the specific antagonist of NKCC1 did not alter
IOS/PS, VSD/PS and IOS/VSD ratios, we conclude that
NKCC1 do not directly contribute to IOS and VSD sig-
nals in the rat hippocampal slice.
To further investigate the mechanism of action of fur-
osemide, we applied VU0463271, a specific inhibitor of
KCC2 (10 μM) [53]. In the presence of VU0463271 PS
amplitude increased to a similar extent as in the case of
furosemide application (PSIOS: 282 ± 37 %, PSVSD: 241 ±
18 % of control). This suggests that the furosemide in-
duced increase in the PS amplitude is mediated by KCC2.
Despite the highly elevated PS amplitude, IOS (100 ±
6 %, 99 ± 7 % and 98 ± 18 % of control in the CA1, CA3
and DG, respectively; N = 5; Fig. 4c) and VSD (101 ±
4 %, 101 ± 3 % and 107 ± 9 % of control in the CA1,
CA3 and DG, respectively; N = 7; Fig. 4c) amplitudes
remained at control level in the CA1, CA3 and DG, and
were only slightly increased at the FP recording site (IOS
at the FP recording site 117 ± 7 %, VSD at the FP record-
ing site 114 ± 6 %, of control). VU0463271 application did
not alter the IOS/VSD ratios but the IOS/PS and VSD/PS
ratios were significantly decreased compared to control
(Table 1). There were no significant regional differences in
drug effect in any of the optical signals, in line with the
uniform expression pattern of the transporter [49].
The fact that VU0463271 could decouple neuronal
activity from the optical signals implies that KCC2 takes
part in the generation of both optical signals. However,
VU0463271 application did not fully resemble the effects
of furosemide, as it did not decrease the IOS and VSD
signals and did not change IOS/VSD ratios. Therefore,
furosemide may partly achieve its inhibitory effect by act-
ing on proteins other than NKCC1 and KCC2, such as by
inhibiting GABAA receptors [54] or the Cl
−/HCO3− ex-
changer [55]. Additional inhibition of GABAA receptor by
furosemide could also explain the increase of VSD amp-
litude by furosemide, but not by VU0463271. Similarly,
inhibitory action of furosemide on the Cl−/HCO3− exchan-
ger might explain why IOS was decreased in the presence
of furosemide, because besides KCC2 the Cl−/HCO3−
exchanger might also play a role in cell swelling [56] and it
is expressed in the hippocampus [57]. However, since the
inhibition of the GABAA receptor by picrotoxin enhanced
IOS, the non-specific effect of furosemide on this recep-
tor could not be responsible for IOS decrease. Alterna-
tively, another possible explanation is that a synergistic
effect arises when NKCC1 and KCC2 are simultan-
eously blocked.
In summary the role of NKCC1 can be excluded from
the generation of optical signals. The results suggest the
KCC2 contributes to both optical signals, but its inhib-
ition by a specific antagonist cannot fully match the ef-
fect of furosemide.
Inhibition of glial potassium clearance differently affects
VSD and field potential
Previous studies concluded that IOS mainly reflects glial
K+ clearance via the NKCC1 transporter [50, 58]. This
conclusion was drawn based on the inhibitory effect of
furosemide, an unspecific blocker of both NKCC1 and
neuronal KCC2. Since we excluded the role of NKCC1
in IOS generation and showed that furosemide likely acts
on the neuronal potassium influx transporter KCC2, the
question arises whether potassium clearance by other pro-
teins significantly contributes to IOS. Moreover, potassium
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clearance was also suggested to contribute to the VSD
signal in skate brain slice [59]. Therefore, we investigated
the role of major potassium clearance routes, the Kir4.1
potassium channel and the glial Na+/K+ ATPase [60–62]
in IOS and VSD signal generation.
Due to the lack of a specific inhibitor for Kir4.1 potas-
sium channel, its role was addressed by the non-specific
blocker BaCl2 (500 μm) [63, 64] on the FP, IOS and VSD
signals. BaCl2 increased PS amplitude (PSIOS: 191 ± 11 %,
PSVSD: 206 ± 31 % of control, Fig. 5a). The IOS amplitude
also increased in the CA1 region and at the FP recording
site (125 ± 7 % and 119 ± 8 % of control) but did not
change in the CA3 and in the DG (108 ± 7 % and 101 ±
8 % of control for CA3 and DG, respectively; Fig. 5a).
VSD signal was not increased by BaCl2 in the whole
CA1 region (97 ± 11 % of control), but it was increased
at the recording electrode site (125 ± 5 % of control).
VSD signal was significantly decreased in the CA3 and
Fig. 5 Inhibition of glial K+ clearance only slightly affects IOS, but significantly decreases VSD transients. a: (Left) Representative VSD amplitude
maps under control condition and 500 μM BaCl2 application. (Middle) Time course of the field potential responses and VSD transients on
the diode at the field potential recording site under control condition and 500 μM BaCl2 applications. (Right) Effect of 500 μM BaCl2 on the
population spike (PS) measured in the CA1 and on the average VSD and IOS amplitudes in the CA1, CA3 and DG regions. b: (Left) Representative
VSD amplitude maps under control condition and 3 μM ouabain application. (Middle) Time course of the field potential responses and VSD transients
on the diode at the field potential recording site under control condition and 3 μM ouabain application. (Right) Effect of 3 μM ouabain on the PS
measured in the CA1 and on the average VSD and IOS amplitudes in the CA1, CA3 and DG regions. On the VSD signal amplitude maps transparent
lines indicate the pyramidal cell layers (CA1 and CA3) and the granular cell layer of the DG. The positions of the stimulating and recording electrodes
are marked by gray and green arrows, respectively. Asterisks indicate significant changes compared to control (P < 0.05, Mann–Whitney U test)
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in the DG (71 ± 5% and 45 ± 6 % of control for CA3 and
DG, respectively; Fig. 5a), suggesting region specific con-
tribution of astrocytes to the VSD signal.
Importantly, besides the Kir4.1 potassium channel,
BaCl2 also inhibits Kir2.x potassium channels [65, 66],
KATP potassium channel [67] and KCNQ1 potassium
channel [68]. However, these channels are localized on
neurons, therefore their inhibition would result in neuronal
depolarization and consequently increased VSD signal
amplitude. The observation that VSD and PS amplitudes
change in the opposite direction suggests that BaCl2 acts
on the astrocytic potassium channels. Since Kir4.1 potas-
sium channel is the most abundantly expressed potassium
channel on astrocytes [69], BaCl2 most likely acts via Kir4.1
potassium channel inhibition.
Besides Kir4.1, the Na
+/K+ ATPase is also responsible
for the glial K+ clearance [62]. Moreover, it was shown
that the glial Na+/K+ ATPase isoform plays a major role
in Schaffer-collateral stimulation evoked extracellular K+
clearance [60]. Since the neuronal α1 isoform of the rat
Na+/K+ ATPase is very insensitive to its inhibitor ouabain
(IC50 > 1 mM) [70–72], we could assess the contribution
of the more ouabain sensitive [73] glial α2 Na+/K+ ATPase
isoform by low concentration (3 μM, [74]) ouabain.
Ouabain application evoked changes in PS, IOS and VSD
amplitudes very similar to those observed for BaCl2
(Fig. 5b). PS amplitude was increased (PSIOS: 154 ± 10 %,
PSVSD: 194 ± 24 % of control). IOS amplitude was not sig-
nificantly increased in the whole CA1 region (111 ± 8 % of
control), but was significantly increased on the diode at
the FP recording electrode site (126 ± 12 % of control).
IOS amplitude did not change in the CA3 and DG regions
(99 ± 5 % and 90 ± 7 % of control for CA3 and DG,
respectively). VSD signal also showed similar pattern as
IOS. In the whole CA1 the VSD signal amplitude
remained at control level (98 ± 3 % of control), but at
the FP recording electrode site VSD amplitude increased
(116 ± 5 % of control). In the CA3 and the DG regions,
the VSD amplitude significantly decreased (90 ± 4 % and
65 ± 9 % of control for CA3 and DG, respectively; Fig. 5b),
similarly to the BaCl2 application.
Conclusively, glial K+ clearance via the Kir4.1 potassium
channel and the glial Na+/K+ ATPase can only be a
minor contributor to the IOS and VSD signals.
IOS can also originate from the increased metabolic
activity of glial cells. To determine if the enhanced mito-
chondrial citric acid cycle activity contribute to IOS or
VSD, we tested the effect of fluorocitric acid (322 μM)
the blocker of the aconitase enzyme [75, 76]. Since fluor-
ocitric acid is available as a Ba2+ salt, we have chosen its
concentration to match the concentration of Ba2+ applied
in the previous experiments. In the presence of fluoroci-
tric acid IOS amplitude increased in the CA1 region and
at the FP recording site (116 ± 10 % and 118 ± 8 %,
respectively) but remained at control level in the CA3 and
in the DG (98 ± 8 % and 84 ± 14 % of control in the CA3
and DG, respectively). At the FP recording site the VSD
signal amplitude remained at control level (82 ± 18 % of
control), but in the CA1, CA3 and the DG VSD amplitude
was significantly decreased (to 68 ± 11 %, 50 ± 10 % and
53 ± 17 % of control in the CA1, CA3 and DG, respect-
ively). Since the results for the fluorocitric acid were not
significantly different from the results of BaCl2 (p < 0.05,
one way ANOVA), we conclude that fluorocitric acid does
not have any effect on IOS and VSD signals.
Assessing the contribution of anion homeostasis to the
optical signals
We have previously shown that the general anion chan-
nel antagonist DIDS (200 μM) decoupled neuronal activ-
ity from IOS [5]. However, it is more appropriate to
compare the IOS signal to the spatial VSD instead of the
locally measured FP. Therefore we compared DIDS effect
on IOS and VSD. Population spike amplitude was in-
creased in both measurements (PSIOS: 267 ± 32 %, PSVSD:
220 ± 13 % of control). VSD signal amplitude increased in
all regions of the slice (120 ± 3 %, 114 ± 3 %, 127 ± 5 % and
119 ± 5 % of control for CA1, CA3 DG, and at the FP
recording site respectively, Fig. 6) with no significant
regional differences. IOS amplitude also uniformly
decreased in all regions (80 ± 9 %, 67 ± 9 % 78 ± 15 %
and 75 ± 6 % of control for CA1, CA3, DG and at the FP
recording site, respectively). Similarly to furosemide
application, the ratio of IOS and VSD signals was
significantly different in all regions compared to control
(Table 1), suggesting that the target of DIDS is a
uniformly expressed protein in the slice. Both IOS and
the VSD changed differently than the PS, indicated by
the significant difference of the IOS/PS and VSD/PS
ratios from the control (Table 1). DIDS shows a behav-
ior similar to furosemide, indicating that the two com-
pounds may have a common target molecule.
Discussion
VSD and IOS imaging are widely used methods for map-
ping neural activity both in vitro and in vivo. Although
these signals pertain spatiotemporal spreading of stimu-
lus evoked neural activity, associated cellular and mo-
lecular activities as well as the involvement of neuro-glia
coupling are not concluded yet. We addressed these
issues by fast imaging in combination with molecular
profiling of IOS and VSD transients evoked by stimulat-
ing Schaffer collaterals in rat hippocampal slices. For
comparison, FP was also recorded from area CA1.
Major findings are summarized as follows: i) glutam-
ate clearance by astroglial glutamate transporter EAAT2
is a major component of both IOS and VSD transients
(Fig. 7); ii) EAAT2 contributes to VSD generation in
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very short time scale (<5 ms); iii) regiospecific contribu-
tion of astrocyte activity to VSD in the order of DG >
CA3 > CA1 correlates with the EAAT2 localization
pattern; iv) activities of neuronal K+/Cl− cotransporter
KCC2, non-specific anion channels, astroglial K+ clear-
ance through Kir4.1 channel and Na
+/K+ ATPase also
contribute to the spatiotemporal IOS and VSD signaling
(Fig. 7); v) IOS and VSD signals are critically dependent
on voltage-dependent Na+ channel activity, GABAergic
disinhibition and postsynaptic glutamatergic activation,
reflecting eventual neuronal origin; vi) despite their
diverse spatiotemporal spreading, the IOS and VSD
amplitudes linearly correlate to the PS amplitude.
Astrocytic Glu uptake shapes spatiotemporal spreading of
VSD and IOS transients
Blockade of IOS and VSD signals by tetrodotoxin and sub-
stantial disinhibitory enhancements by picrotoxin support
causal relationship between spatiotemporal spreading
of neuronal excitation and VSD/IOS transients. IOS
and VSD transients have previously been suggested to
reflect postsynaptic activation of neurons [8, 23, 77–80].
In accordance, we found that both IOS and VSD tran-
sients were significantly decreased in the presence of
ionotropic glutamate receptor AMPA/kainate and NMDA
antagonists.
Importantly, however, we also identified significant
astrocytic components in both the VSD and IOS signals.
Astrocytes have a key role in glutamatergic neuro-
transmission, since Glu is mainly taken up by astrocytes
[81–83]. Therefore astroglial Glu uptake can be a plausible
component process of the spatiotemporal optical signals
[6, 84]. We have recently reported [5] that DHK, a select-
ive blocker of the astroglial Glu transporter EAAT2 had
distinct effects on IOS and PS measures of neural activity,
indicating a direct role for astrocytic Glu uptake mediated
cell swelling in IOS generation. Surprisingly, DHK differ-
entiated not only between IOS and PS, but also between
VSD and PS. To confirm this unexpected result, we also
determined the DHK effect not only regarding the
whole CA1 region, but also on the single photodiode at
the FP recording electrode site. The direct comparison
of the VSD and FP transients from the same location
still showed distinct DHK effects on VSD absorbance
and FP traces, excluding the possibility that spatial
averaging of the VSD transients introduced the EAAT2-
sensitive component.
The effect of DHK on the VSD signal and PS amplitude
can be either direct by decreasing glial EAAT2 transporter
currents or indirect by increasing interneuron firing rate
[85] or desensitizing Glu receptors. Indirect effect of DHK,
however, can be excluded since PS amplitude increased in
the presence of DHK, indicating enhanced neuronal activ-
ity due to increased extracellular [Glu]. Therefore, we can
conclude that the EAAT2 transporter directly contributes
to the generation of VSD signal.
Fig. 6 DIDS enhances VSD and decreases IOS transients. (Left) Representative VSD signal amplitude maps under control condition and 200 μM
DIDS application. Transparent lines indicate the pyramidal cell layers (CA1 and CA3) and the granular cell layer of the DG. The positions of the
stimulating and recording electrodes are marked by gray and green arrows, respectively. (Middle) Time course of the field potential responses and
VSD transients on the diode at the field potential recording site under control condition and 200 μM DIDS application. (Right) Effect of 200 μM
DIDS on the population spike (PS) measured in the CA1 and on the average VSD and IOS amplitudes in the CA1, CA3 and DG regions. Asterisks
indicate significant changes compared to control (P < 0.05 Mann–Whitney U test)
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EAAT2 is mainly expressed on glial cells [86–90], and
glial cells are responsible for the majority of Glu uptake
[83, 88]. It should be noted, however, that EAAT2 expres-
sion was also demonstrated on neuronal axon terminals
and axons [91–93]. However, in contrast to the synapse-
facing glial EAATs, neuronal EAAT2 is located extrasynap-
tically [94], therefore its activation requires Glu to escape
the synapse. Accordingly, significant capacity of neuronal
Glu uptake could only be observed when exogenous sub-
strates were applied [92, 95] and it is concluded that neur-
onal EAAT2 do not play significant role in the removal of
synaptically released Glu [83, 96]. In addition, we demon-
strated the inhibitory effect of DHK on VSD in a very short
time scale (<5 ms) that probably does not allow Glu escape
from the synapse. Therefore, the neuronal EAAT2 is less
likely to contribute to the VSD signal in the observed (>10
%) extent. Moreover, inhibition of neuronal Glu (and
coupled sodium) uptake would lead to hyperpolarization of
neurons which is in contrast to the measured increase in
the PS amplitude. Conclusively, we propose that it is the
glial EAAT2 that plays a major role in VSD generation.
We have demonstrated that DHK decreases VSD
amplitude that appears within 5 ms from the stimulus,
suggesting glial contribution in a very short time scale.
Despite glial cells are generally considered to be slow
responding cells that operate on longer time scales [97],
several studies have demonstrated that glial Glu trans-
porter currents do appear within this very short (<5 ms)
interval after synaptic activation [94, 98, 99]. In addition,
neurotransmitter transporters are slowly transporting
their substrates, again arguing against the quick contri-
bution of EAAT2 in VSD generation. However, despite
the slow transport cycles, Glu transporters are able to
Fig. 7 Molecular dissection of processes underlying spatiotemporal
IOS and VSD generation. a: Neuronal and glial proteins underlying
VSD mechanism. First, stimulus of the Schaffer collaterals depolarizes
neurons via Glu receptor activation. The released Glu almost
instantly activates glial EAAT2, therefore the first 5 ms of the VSD
signal represents both neuronal and glial depolarization. Neuronal
depolarization leads to additional Glu release and the elevation of
extracellular [K+] and alteration of extracellular [Cl−]. The elevated
extracellular [K+] activates glial Kir4.1 channel and Na
+/K+ ATPase
which are responsible for the late VSD response. The altered
extracellular [Cl−] leads to the activation of non-specific anion
channels and transporters which also contribute to the VSD signal.
b: Neuronal and glial proteins underlying IOS mechanism. First,
neurons in the pyramidal layer are activated by Schaffer collateral
stimulation leading to swelling of their soma, followed by swelling
of glial cells in the dendritic region. Glial activity related IOS appears
as the consequence of neuronal activation. Neurons induce glial
IOS through altered extracellular [K+] and [Cl−] concentration by
depolarization, by their KCC2 cotransporter and by the release of
glutamate. IOS is mediated on glial cells via the EAAT2, anion
channels and transporters, Kir4.1 channel and Na
+/K+ ATPase.
Proteins underlying VSD or IOS mechanism are sized in accordance
with their contribution to IOS and VSD genesis
Pál et al. Molecular Brain  (2015) 8:35 Page 13 of 20
generate quick currents due to their high density. The
number of EAAT2 proteins in a single CA1 synapse is
3–5 times higher than the number of Glu molecules in a
synaptic vesicle [87]. Therefore even one transport cycle
can be sufficient to remove all the released Glu molecules.
In contrast to our results, previous studies showed
only significantly delayed astrocytic contribution to VSD
signaling (>10 ms) that was considered as a depolarization
response [6]. It should be noted that we have also seen
this delayed astrocytic contribution to the VSD signal in
the presence of DHK. The apparent conflict between these
results may be attributed to the different locations the
VSD signals were acquired relative to the stimulus site.
Kojima et al. measured VSD responses in the close vicinity
of the stimulation electrode, while we detected VSD sig-
nals at several hundred μm away from the stimulation
electrode. In our experiments, the signals on diodes close
to the stimulation site in the CA3 could not be evaluated
due to the large artefacts likely caused by vessel dilation.
Another important issue regarding the EAAT2-
mediated components of the VSD signal is why it does
not appear on the FP responses, despite the common
parameter (membrane potential fluctuations) probed by
the two methods. We propose that this apparent discrep-
ancy may be due to the expression profile of EAAT2.
EAAT2 is located on perisynaptic astroglial processes
[100] and the overall surface of these processes largely ex-
ceeds the membrane area of the soma and main processes
[101]. VSD is bound to the cell membrane [102] over the
full membrane surface, therefore it can adequately probe
the membrane potential changes of the astrocyte pro-
cesses, which are hardly detectable even by patch clamp
recording [98, 103].
By identifying the monosynaptically activated region,
we also quantified the contribution of glial EAAT2 to the
generation of the VSD transients. The EAAT2-sensitive
component was found to be a major portion (>10 %) of
the total VSD signal. These findings provide evidence
for the critical role for astrocytes and neuro-glia interac-
tions [104–106] in the generation of VSD transients for
the first time.
Contribution of anion homeostasis to VSD and IOS signals
The general anion channel antagonist DIDS increased
PS amplitude in the CA1 by 120 ± 13 %, but enhanced
VSD only by 20 ± 3 %. The differential effect of DIDS
suggests that its target proteins contribute not only to
IOS [5], but also to the VSD signal (this work). Since
DIDS may act on multiple targets, including the mito-
chondrial inner membrane anion channel [107], Kv4.2 and
Kv4.3 potassium channels [108], chloride channels [109],
transient receptor potential cation channel subfamily C
member 4 (TRPC4), transient receptor potential cation
channel subfamily M member 4 (TRPM4) [110], transient
receptor potential cation channel subfamily V member 1
(TRPV1), RAD51 recombinase [111], Na+/CHO3
− cotran-
sporter [112] and Cl−/HCO3− exchanger [113], it is diffi-
cult to determine which target or targets are responsible
for its effect on the optical signals. Inhibition of neuronal
TRPM4, TRPC4, Kv4.2 or Kv4.3 potassium channels by
DIDS would lead to decreased depolarization and conse-
quently decreased PS amplitude. Therefore, these target
molecules are not likely to mediate DIDS effect. TRPV1
currents are potentiated by DIDS, but the activity of this
channel is associated with synaptic depression [114],
thus TRPV1 may also be excluded from the potential
mediators. Since IOS has been shown to be sensitive to
the alteration of the chloride gradient [79], the most
probable target molecules of DIDS are the anion chan-
nels, Na+/CHO3
− cotransporter or Cl−/HCO3− exchan-
ger. Notably, these proteins are expressed on glial cells
[43, 115–117], which can also explain why VSD is
decoupled from neuronal activity in the presence of DIDS.
Since DIDS effect on FP and VSD signals was compar-
able to furosemide, our findings may conjecture furosem-
ide and DIDS sharing a common target involved in IOS
and VSD generation.
Contribution of astrocytic K+ clearance to VSD and IOS
transients
By addressing the role for Kir4.1 potassium channel in
VSD and IOS transients with BaCl2, a non-specific in-
hibitor of the Kir4.1 potassium channel we observed simi-
lar effects on amplitudes of both PS and optical signals
in the CA1. However, despite of the increased PS and
VSD amplitudes, the integral of the VSD transient sig-
nificantly decreased in the CA1 due to the altered VSD
curve shape. In addition, the IOS/VSD amplitude ratio
also suggested distinct contributions of Kir4.1 activity to
IOS and VSD signals in the CA3 and DG regions. Simi-
larly to the Kir4.1 channel inhibition, blockade of the
astroglial Na+/K+ ATPase resulted in region-specific
changes in IOS/VSD ratios. Since Kir4.1 channel and
astroglial Na+/K+ ATPase inhibition did not decouple
the PS and optical signal amplitudes, they likely do not
play major roles in IOS and VSD generation. The
region-specific IOS/VSD ratios and the distinct effect of
Kir4.1 channel inhibition on the PS amplitude and VSD
integral, however, suggests that they play minor role in
VSD and IOS signals. It is to note that their contribu-
tion can also be indirect via interfering astrocyte glu-
tamate uptake [88].
Conclusion
Molecular dissection of VSD and IOS transients com-
bined with simultaneous, time-aligned field potential re-
cordings have highlighted the role of various membrane
proteins in the generation of the two widely used optical
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readout of neural activity. Importantly, both signals have
been shown to be rooted from a mixture of neuronal
and glial processes. Contrary to the general view of IOS
that attributes signal genesis mostly to glial cell swelling,
we identified a significant neuronal component mediated
by the K+/Cl− cotransporter KCC2. Surprisingly, our
findings also suggest that the interpretation VSD signals
as spatially extended field potentials may not be relevant,
since the VSD transients contain a significant astroglial
component that is not present in the field potentials.
Molecular entities mediating this VSD-specific astrocytic
component have been identified as the EAAT2 glutam-
ate transporter (major) and possibly the Kir4.1 channel as
well as the astroglial Na+/K+ ATPase (minor). Therefore,
neither VSD imaging can be considered as a predomin-
antly neuronal signal, nor IOS should be associated with
primarily glial processes. Instead, both optical signals obey
astroglial responses to neuronal activity. These findings
constitute neuro-glia communication as the origin of
spatiotemporal optical signals within the brain.
Methods
Ethical approval
Animals were kept and used in accordance with the
European Council Directive of 24 November 1986 (86/
609/EEC), the Hungarian Animal Act, 1998. All experi-
ments involving animals were done by the approval of
the Animal Testing Committee of the Research Centre
for Natural Sciences, Hungarian Academy of Sciences and
by the approval of the Ministry of Agriculture and Rural
Development, Hungary. All efforts were made to reduce
animal suffering and the number of animals used.
Chemicals
Picrotoxin, DIDS, fluorocitric acid, barium chloride and
furosemide were purchased from Sigma-Aldrich Co. (St.
Lois, MO, USA). Tetrodotoxin (TTX), DHK, ouabain,
VU0463271 and bumetanide were purchased from Tocris
Bioscience (Bristol, UK). CNQX and APV were purchased
from Abcam Biochemicals (Cambridge, UK).
Brain tissue slices
Transverse, 400 μm thick hippocampal-entorhinal cortex
slices from juvenile (P21-50) male Wistar rats (Toxi-
coop, Budapest, Hungary) were prepared in modified
artificial cerebrospinal fluid (ACSF, in mM: 75 sucrose,
87 NaCl, 2.5 KCl, 1.25 NaH2PO4, 7 MgSO4, 0.5 CaCl2,
25 NaHCO3, 25 glucose, continuously bubbled with 95%
O2 + 5% CO2 gas mixture) at 4°C, as described before
[118]. Slices were incubated in an interface-type cham-
ber that was continuously circulated by ACSF for 1 h at
37°C (followed by incubation at room temperature)
before performing the experiments in a submerged type
recording chamber perfused with carbogen gas-saturated
ACSF (containing in mM: 129 NaCl, 10 glucose, 3 KCl,
1.25 NaH2PO4, 1.8 MgSO4, 2 CaCl2, 21 NaHCO3, pH
7.4, 36 °C) at a rate of 3–4 ml/min. All drug effects were
measured in at least two animals.
Voltage-sensitive dye staining
For VSD imaging slices were stained for 10 min at
room temperature in 1ml bubbled ACSF containing
0,307 μM voltage-sensitive absorbance dye NK3630
(RH482, Hayashibara Biochemical Laboratories, Okayama,
Japan) [119, 120] in a custom designed interface chamber
(1,2 ml total volume). Then slices were washed three times
in the small interface chamber by 1 ml ACSF and kept in
the dark for 1 h before the experiment. NK3630 dye was
only applied for VSD measurements except one case,
when the spatial extent of VSD and IOS were compared
in the same slice (Fig. 1a).
Schaffer collateral stimulation
Single square wave pulses of 0.2 ms duration were de-
livered through a bipolar tungsten electrode (75 μm
diameter, Microprobes for Life Science), placed in the
trajectory of the Schaffer collaterals in the str. radia-
tum of the CA3 region. Each stimulus was preceded by
a 200 ms long delay period for baseline calculations.
Stimulation intensity was set to evoke half maximal
field response (40–50 V). Different stimulation proto-
cols were used to evoke IOS (10 stimuli/20 Hz) and
VSD (single pulses) signals. The differences between
the stimulation protocols were made to clearly discrim-
inate the two, spectrally overlapping signals. IOS can-
not be evoked by one stimulus [5], therefore a single
pulse specifically evokes VSD. VSD, however, cannot be
reliably measured using a stimulus train, because it
lasts longer than the interstimulus interval (50 ms),
therefore its amplitude is summed during the train. In
all experiments VSD was evoked by a single stimulus
while the IOS was evoked by a 20 Hz stimulus train.
When comparing the spatial extent of VSD and IOS,
optical signals were recorded from the same slice, but
were evoked by different stimulus protocols (Fig. 1a).
Three or five trials were taken in every 10 min for IOS
and VSD measurements, respectively.
Optical recording
Optical signals were detected by a 464-element photo-
diode array (PDA) detector having temporal resolution
of 0.6 ms, making it achievable to align the optical
signals with the simultaneously measured FP recordings.
For both type of optical measurement, IOS and VSD,
slices were illuminated with a halogen lamp source (max-
imum intensity: 100 W) passed through a band-pass filter
(700 ± 40 nm, Chroma Technology, Rockingham, VT). For
the validation of the VSD signal a 500 ± 40 nm (Chroma
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Technology, Rockingham, VT) and a 650 ± 3 nm (Knight
Optical (UK) Ltd, Harrietsham) band-pass filters were also
used. As expected [120], no VSD signal could be observed
at 650 nm, a small positive amplitude signal was measured
at 500 nm and the highest amplitude signal was detected
at 700 nm (Fig. 8).
The transmitted light was collected by a Wutech
H-469IV photodiode array that is part of a Redshirt
Imaging integrated Neuroplex II imaging system,
mounted on the front port of an Olympus BX51WI
microscope (10x objective, 1.6 kHz sampling frequency,
500× amplification, 0.5 Hz high-pass filtered [119]).
Each diode in the array corresponds to an approxi-
mately 70 × 70 μm square area. Data were acquired
using the Neuroplex software.
Field potential recording
Field potential recording electrodes (2–5 MΩ) were
filled with ACSF and placed in the CA1 pyramidal cell
layer. Recordings were performed with a two-channel
Multiclamp 700A amplifier (Axon Instruments, Foster
City, CA, USA). Traces were low-pass filtered at 2 kHz
and digitized at 10 kHz with a Digidata 1320A A/D
converter (Axon Instruments, Foster City, CA) controlled
by a computer running pClamp8 (Axon Instruments,
Foster City, CA, USA).
Drug application
After recording at least two control trials, drugs were
perfused in the recording chamber at a rate of 3–4 ml/
min. For evaluating drug effects, the trials were taken
after 5 min of drug application.
The stability of the electrophysiological and optical sig-
nals were tested in the timeframe of the drug application
experiments. Control measurements were performed, in
which no drug was added, but the parameters of the sig-
nals were calculated in the same way as in the case of drug
application. IOS amplitude was slightly, but significantly
higher in the CA1 and CA3 regions after 3 control trials
(106 ± 4 %, 108 ± 3 % of control in the CA1, and in the
CA3, respectively N = 5, p < 0.05), while the field potential
and VSD amplitudes showed no changes (N = 8). Drug
effects were considered significant if the changes exceeded
two times the baseline change.
In the experiments in which ouabain was applied,
slices showing <70 % of the control FP amplitude were
excluded from further data analysis.
Immunohistochemistry
Three rats were deeply anesthetized and perfused trans-
cardially with 150 ml saline followed by 300 ml of ice-
cold 4 % paraformaldehyde prepared in 0.1 M phosphate
buffer at pH 7.4 (PB). Brains were removed and postfixed
in 4 % paraformaldehyde for 24 h and then transferred to
PB containing 20 % sucrose for 2 days. Serial coronal sec-
tions were cut at 50 μm on a sliding microtome from a
block that included the hippocampus. Sections were
collected in PB containing 0.05 % sodium-azide and
stored at 4 °C.
Every fourth free-floating brain section was immuno-
stained for EAAT2 using a monoclonal mouse anti-
EAAT2 antiserum (mouse anti-EAAT2, cat# ab77039,
Abcam, Cambridge, UK). This antiserum (1:500) was ap-
plied for 48 h at room temperature followed by incuba-
tion of the sections in biotinylated donkey anti-mouse
secondary antibody (1:1000 dilution; Jackson Immuno-
Research, West Grove, PA) for 1 h and then in ABC
complex (1:500; Vector Laboratories, Burlingame, CA)
for an additional 1 h. Subsequently, EAAT2 immunore-
activity was visualized by incubating the sections in 0.02
% 3,3-diaminobenzidine (DAB; Sigma), 0.08 % nickel(II)
sulfate, and 0.003 % hydrogen peroxide in PB. Finally,
the sections were mounted, dehydrated and coverslipped
with Cytoseal 60 (Stephens Scientific, Riverdale, NJ).
Primary data processing and data analysis
The population spike (PS) amplitude was calculated ac-
cording to Anderson and Collingridge [121] as the amp-
litude from the PS onset to the intersection with a
tangent line drawn between the PS onset and the PS
offset. For the IOS experiments, the amplitudes of the
10 evoked PS responses in the stimulus train were
summed and compared to the sum IOS amplitude.
The intensity values on each diode were divided by the
resting (background) light intensity on the same pixels
to reduce regional differences in scattering properties
or staining level. IOS and VSD signals were smoothed
with local regression method using weighted linear
least squares and a 2nd degree polynomial model [122].
The detected optical signal peaks were accepted if the
signal to noise ratio has exceeded 5.
Fig. 8 Spectral characteristics of recorded VSD. VSD signals detected
at different illumination wavelengths
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Drug effects were quantified by calculating the amplitude
(difference between the peak intensity after the stimulus
and the average of baseline intensity level recorded before
the stimulus) and integral (the area under curve from the
onset to the point when the signal reached the baseline
level) of IOS and VSD transients. Regional IOS and VSD
parameters were calculated for the whole CA1, CA3 and
dentate gyrus by summing amplitudes on all diodes in the
selected region. Diodes close (<100 μm) to the stimulating
electrode were excluded from the analysis due to the large
movement artifact following the stimulus.
To characterize the spreading pattern of the optical
signal, the time point where the IOS or VSD curve reaches
50 % of its amplitude was also calculated (referred to as
50 % delay). We have chosen this method because the
location of maxima of the optical signals (especially in the
case of IOS) could not always be reliably identified.
Spreading velocity of the VSD was estimated by dividing
the distance between two diodes by the difference between
the 50% delay points of the two neighboring VSD signals.
The correlation between the FP and optical signals
was assessed by calculating the ratio of IOS or VSD am-
plitudes (expressed in % of control) for the whole CA1
region and the PS amplitude measured in the CA1 str.
pyramidale. The correlation between the two optical
signals was defined by calculating the ratio of IOS and
VSD amplitudes (both expressed in % of control) for the
CA1, CA3 and the DG regions.
The spatial pattern of the optical signals during con-
trol and drug application was visualized by generating
2D images depicting IOS or VSD amplitudes.
Statistics
To evaluate drug effects (between the control trials and the
drug application from the same region) Mann–Whitney U
test was used with P < 0.05 considered significant. For re-
gional differences in the optical signal parameters one-way
ANOVA was used with P < 0.05 considered significant.
Data are reported as means ± SEM. Data processing,
analysis, and graphical representations were performed with
pClamp9 (Axon Instruments), Origin 9.0 (Origin-Lab)
software and custom written scripts in MATLAB 6.5
(MathWorks, Nattick, MA) environment.
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